Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE: Adalimumab for Moderate to Severe Crohn's Disease
NCT00409617Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Dec 2006
- Primary completion
- Jul 2008
- Modality
- Monoclonal Antibodies
- Countries
- 17
01
Overview
A Phase 3 trial of adalimumab in Crohn's disease, sponsored by Abbott Laboratories. Started Dec 2006; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00409617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409617.